Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006031 · ClinicalTrials.gov registry record · NA
Comparison of Two Types of Biopsy in Patients With Breast Lesions
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 117
- Enrollment target
NCT00006031: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT00006031 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006031, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
Study Summary
RATIONALE: Biopsy is the removal of cells or tissue for examination under a microscope. It is not yet known which type of breast biopsy is more effective for diagnosing breast lesions. PURPOSE: Randomized diagnostic trial to compare the effectiveness of two different types of biopsy in patients who have breast lesions that cannot be felt upon examination.
Primary Outcome
Compare the effect of low dose radioactive seed localized breast biopsy versus needle localized breast biopsy on tissue loss in patients with nonpalpable breast lesions.
Interventions
- PROCEDURE Needle localized breast biopsy with specimen x-ray
- PROCEDURE Low dose radioactive seed followed by surgery and mammogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 1999-11 |
| Est. Completion | 2006-07 |
| Phase | NA |
What the finished NCT00006031 record still lists
NCT00006031 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Needle localized breast biopsy with specimen x-ray is the first listed.
NCT00006031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006031 about?
NCT00006031 is a clinical study titled "Comparison of Two Types of Biopsy in Patients With Breast Lesions". RATIONALE: Biopsy is the removal of cells or tissue for examination under a microscope. It is not yet known which type of breast biopsy is more effective for diagnosing breast lesions. PURPOSE: Randomized diagnostic trial to compare the effectiveness of two different types of biopsy in patients who...
What is the current status of trial NCT00006031?
This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 1999-11. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00006031?
The interventions under investigation include: Needle localized breast biopsy with specimen x-ray (PROCEDURE), Low dose radioactive seed followed by surgery and mammogram (PROCEDURE).
Who is sponsoring clinical trial NCT00006031?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00006031's enrollment target sits among peer trials
117 807th of 2000 higher than 1,193 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia